RimonabantReport
Your INDEPENDENT source of news and reviews about the new diet drug rimonabant
 
This news site is NOT affiliated with NOR endorsed by Sanofi-Aventis, which markets rimonabant as Acomplia®
 
 
  Rimonabant News from May 2007 -- News About Rimonabant

Raids in Europe Crack Ring Selling Counterfeit Acomplia on Internet

 

Simultaneous police raids conducted on April 24, 25 and 26 involving five European countries resulted "in the dismantling of a network of internet sales of counterfeit pills of the drug Rimonabant (Acomplia),” according to Eurojust, the European Union's Judicial Cooperation Unit.

The investigation, initiated by the public health department of the Paris public prosecutor's office, led to a coordinated series of searches based on European Arrest Warrants in Sweden, Denmark, the Netherlands and Romania.

The raids and arrests were the culmination of an eight-month investigation which began after a U.K. citizen was apprehended in France with a single bottle of counterfeit Acomplia.

The French investigators said they had uncovered an international traffic in counterfeit Acomplia, "produced in unhygienic environments," then sold over the internet and consumed "in amounts in violation of the regulations and without any medical control."

Eurojust did not provide names or web addresses of the internet sites selling the counterfeit Acomplia.

"The counterfeiting of such pills constitutes a serious fraud and an important health risks as they are made widely available via the internet to all consumers, including minors," a Eurojust spokesperson said.

The raids within the different countries were led by officers from France's Central Brigade for Industrial and Artistic Fraud and the Central Office for the Fight Against Crimes using Technology and Communications.

 
 
 
 
 

 

Other Diet Resources
Privacy Policy | Terms and Disclaimers | About the Rimonabant Report
Click to VerifyWe subscribe to the HONcode principles of the HON Foundation.

This is an independent news site reporting on rimonabant, a diet drug developed by Sanofi-Aventis which markets it in Europe as Acomplia. Nothing on this site is intended to infringe on that trademark. Nothing on this site is intended as medical advice. The information provided here is for informational purposes only. Always consult a doctor or medical professional with questions you may have regarding a medical condition.

(c) 2004-2007 Medical Week News, Inc. All Rights Reserved

Last Updated: 05/30/2007